US3800792A - Laminated collagen film dressing - Google Patents
Laminated collagen film dressing Download PDFInfo
- Publication number
- US3800792A US3800792A US00244439A US3800792DA US3800792A US 3800792 A US3800792 A US 3800792A US 00244439 A US00244439 A US 00244439A US 3800792D A US3800792D A US 3800792DA US 3800792 A US3800792 A US 3800792A
- Authority
- US
- United States
- Prior art keywords
- collagen
- dressing
- film
- compressed
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 89
- 108010035532 Collagen Proteins 0.000 title claims abstract description 89
- 229920001436 collagen Polymers 0.000 title claims abstract description 83
- 239000006260 foam Substances 0.000 claims abstract description 29
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920002635 polyurethane Polymers 0.000 claims abstract description 15
- 239000004814 polyurethane Substances 0.000 claims abstract description 15
- 230000005540 biological transmission Effects 0.000 claims abstract description 14
- 229910052709 silver Inorganic materials 0.000 claims description 14
- 239000004332 silver Substances 0.000 claims description 14
- 229920006255 plastic film Polymers 0.000 claims description 13
- 239000002985 plastic film Substances 0.000 claims description 13
- 206010052428 Wound Diseases 0.000 abstract description 19
- 208000027418 Wounds and injury Diseases 0.000 abstract description 19
- 239000000853 adhesive Substances 0.000 abstract description 7
- 230000001070 adhesive effect Effects 0.000 abstract description 7
- 239000002861 polymer material Substances 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000006185 dispersion Substances 0.000 description 10
- 239000011148 porous material Substances 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920006264 polyurethane film Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 241000287433 Turdus Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/08—Collagen
Definitions
- ABSTRACT A surgical dressing thatv is particularly useful for the treatment of burn wounds is disclosed made from a thicker layer of a collagen compressed foam film to which has been laminated, without any adhesive, a thin continuous layer of an inert polymer material,
- polyurethane such as polyurethane, having a moisture vapor transmission rate slightly higher than that of human skin and which preferably also contains finely divided silver metal impregnated in the collagen layer.
- the status quo of the wound site must be maintained awaiting autografting to complete the treatment. Since in many cases a period of time will pass before autografting is possible, the maintenance of the status quo wound site, i.e. the granulation bed, is an absolute necessity.
- the present methods used to maintain the status quo are by the repeated applications of wet gauze dressings or by employing a temporary homograft or heterograft.
- the repeated application of wet dressings is not particularly satisfactory as these dressings require frequent changes within any 24-hour period and tend to add to the discomfort of the patient. Homografts and heterografts have been found to be effective, but they are not readily available.
- An object of the present invention is therefore to develop a material which can be considered a substitute for a homograft or a heterograft and which will maintain the wound site, i.e. the granulation bed, in a status quo condition until an autograft becomes feasible.
- Moisture vapor transmission rate is the weight of water lost by evaporation through a film membrane at 37C over a period of 24 hours. The weight loss is determined using a Twing Albert permeability cap in a Blue M Electric Company Model POM-203A forced air oven at 37C. The weight loss is observed periodically over a 24 to 48 hour period. This moisture vapor transmission rate figure will vary if measured by other possible procedures, and all rates described herein are those measured by the above method.
- our dressing is composed of a thicker layer (that which will be placed on the skin in actual use) of reconstituted collagen formed into a compressed tanned collagen foam film to which is laminated a thinner outer layer of an inert polymer plastic material, preferably polyurethane.
- a greatly preferred embodiment contains finely divided silver impregnated and distributed through the collagen layer.
- Our new dressing can be 3-30 mils thick and is preferably about 18 mils thick.
- the dressing of our invention can have a moisture vapor transmission rate of from 2 to 7 mg/hr/cm and preferably has a rate of 3 mg/hr/cm.
- Collagen in various forms has been used together with various other materials in the treatment of wounds and of burns.
- Braun, US. Pat. No. 3,491,760 discloses a skin used in heterotransplantation which is made from two different tanned collagen gel layers. The material is used to produce a heteroplastic skin by acting as a suitable nutrient medium. The layer next to the skin has a large-celled, foamy consistency (but is not a compressed foam), and it is covered by a collagen film which is very tough, elastic, and almost leathery to prevent the drying out of the first film.
- an adhering plastic film such as polyvinylchloride foil
- the heteroplastic skin thus formed is fairly thick (the collagen foamy layer being well over mils thick and much thicker than that which applicants use).
- the various layers are cemented together with adhesives.
- a collagen foil dressing product that appears to be made by this method has been sold in Germany. This prior art dressing appears to have a moisture vapor transmission rate different from that of the instant invention.
- Battista US. Pat. No. 3,471,598 discloses freeze drying a dispersion of a microcrystalline collagen to form a mat, which can be used in various applications including surgical dressings.
- FIG. 1 is a plan view of a microphotograph showing the top 10 (i.e. the part away from the skin in actual use) of the surgical dressing of the present invention taken at 3,000 times magnification, and it shows the outer surface of the thinner polyurethane layer 12, which contains a great many microscopic pores 14.
- FIG. 2 is an inverted plan view of a microphotograph showing the bottom 20 (i.e. the part which goes next to the skin in actual use) of the surgical dressing of the present invention taken at 10,000 times magnification, and it shows the outer. surface of the thicker compressed collagen foam 22, which contains a network of collagen fibers or fibrils 24 with pores or open spaces 26 between the collagen fibers or'fibrils.
- FIG. 3 is a diagrammatic cross-section view on line 3-3 from FIG. 1 showing a side view through the center of the surgical dressing of the present invention. It shows the polyurethane layer laminated to the compressed collagen foam layer 20. Also visible in FIG. 3 are the pores 14 in the polyurethane, the collagen fibers 24 and the open spaces 26 between the collagen fibers, and the particles of silver metal 28 impregnated in the collagen foam 20.
- the compressed collagen foam film used in the surgical dressing of the instant invention may be made from collagen obtained from various sources as long as it has the necessary properties hereinafter described.
- Bovine collagen is the most common source. In particular, we have found satisfactory results may be obtained from a commercial product which is marketed by FMC Corporation under the trademark Avitene" or very small, fine, fluffy, collagen fiber particles which are relatively soft and not degraded, made as described in US. Pat. No. 3,471,598 and other patents assigned to FMC Corporation.
- Other usable collagen fibers are those used in the gels from which collagen sausage casings are extruded, which have been ground or milled to the smaller, fine, fiuffy sizes used here. Bovine hide-dried, ground, or milled-can also be used to make the gel from which the compressed foam of the present invention is made.
- the starting collagen is separated into very fine, fluffy fibers (dry to feel and touch) on the order of 25, 35, and 50 mesh size.
- Avitene is sold as a dry fibrous blend of finely divided collagen fibers. These are screened through various sized sieves to separate the collagen into fibers of the same relative size on the order of 25-50 mesh. While specific size and mixtures of size is not critical and smaller or larger pieces of collagen could be used, we prefer to use equal parts of several different sizes, e.g. of 25, 35, and 50 mesh, blended together.
- the collagen fibers are then made into an aqueous dispersion with water, which dispersion contains about 3.5 percent by weight of said collagen fibers. The dispersion is homogenized and allowed to stand.
- the time of standing is not critical, but we have found 1 hour to be satisfactory.
- a fast evaporating organic solvent such as petroleum ether is added to the amount of about percent by volume.
- the purpose of using the organic solvent is to prevent complete selfbonding of the fibers in the reconstituted product.
- the petroleum ether is added to the initial aqueous dispersion. Where a dry collagen other than Avitene has been used, the resultant blend is then acid swollen in the well known fashion (we prefer to use 0.8 percent by weight of lactic acid, but other acids or amounts should work also) and allowed to stand. Where Avitene is used, this step is omitted since the material is already in the acid state.
- the fibers are swollen by the action of the lactic acid and take up the liquid present in the dispersion to form a gel.
- the gel is preferably permitted to stand long enough to attain equilibrium, e.g. for an hour, before being used in the next step of the process.
- the above gel which contains acid swollen collagen, is spread into a thick wet film on the order of about 25 to mils, preferably 50 mils thick.
- the thickness of this thick wet gel film can vary, of course, depending on the desired thickness of the collagen layer in the desired end product dressing. It is next desired to impart further porosity to the collagen film so it will be somewhat foamy and also to tan (i.e. to cross-link) the collagen.
- foaming agents and tanning agents could be used.
- the glutaraldehyde is the tanning agent.
- the sodium bicarbonate is used to control the porosity of the film since it introduces uniform size gas bubbles while the acid swollen film is being neutralized with bicarbonate ions.
- the resultant porous collagen film which has now been neutralized with bicarbonate, has had its constituent collagen deswollen so it now has a lesser thickness about one-half its former swollen size. It is then dried, e.g. by air drying. The resultant dried porous collagen film is well rinsed with water. We prefer a rinsing time of 1 hour. The water-rinsed film is then plasticized slightly. A suitable method is by soaking in 20 percent glycerol for 15 minutes.
- the dried film contains an excess of glutaraldehyde.
- the wet plasticized porous collagen film is dried and is also slightly compressed, i.e. to about onequarter of its original wet thickness (referring to the gel stage), for example, by being force dried on a heated cam under slight pressure.
- a typical thickness of the dried compressed collagen foam film at this point is about 12.5 mils.
- the compressed collagen foam has been fairly well tanned so that it will not have antigenic activity.
- One method of determining the sufficiency of amount of tanning is by its resistance to collagenase attack.
- resistance to collagenase attack is assayed according to a procedure described by Mandl, I. in the J. Clinical lnvestigation, 32, I323 (1953).
- We have found that our cross-linked collagen is essentially resistant to hydrolysis by the enzyme collagenase from Cl. histolyticum. We have reduced the ability of the enzyme to attack the collagen by greater than percent.
- Tollens reagent which has the formula Ag(NH Ol-l, is a reducing agent for aldehyde groups, and it serves to oxidize the excess glutaraldehyde and also to deposit silver metal on the accessible surfaces of the collagen fibers throughout the film.
- the specific amount of silver deposited or impregnated is that which is equivalent to the amount of excess aldehyde which has been oxidized to carboxyl.
- the silver acts as an antibacterial agent and is especially effective in amounts of from 1.5 mg silver per square inch to 0.5 mg silver per square inch when applied and impregnated in the manner herein suggested.
- the collagen film after being soaked in Tollens reagent for 5 minutes, is then rinsed in water for about an hour and finally plasticized, e.g. by being soaked in 20 percent glycerol for minutes, and it is then air dried.
- a typical compressed collagen foam film formed at this point might have a density of 1.8285 grams per cubic centimeter, a porosity of 76.4 percent, and a measured pore volume of 0.608 cubic centimeters per gram (as determined in the well-known manner on a Porosimeter, the particular machine being that manufactured by the American Instrument Company as their Aminco Digital Readout Porosimeter, 15,000 PSI Motor Driven).
- the plastic we prefer is polyurethane, although other plastics ought work provided they give the desired moisture vapor transmission rates (slightly higher than that of skin) and do not release toxic or irritant chemiclas to the wound bed.
- the particular preferred polyurethane is a thermoplastic polyurethane sold by the B. F. Goodrich Chemical Company as Tuftane packaging film and which has high elongation and excellent stretch recovery properties as well as good strength and toughness.
- Tuftane No. 1 1O film in 1.0 mil thickness and dissolved it in an organic solvent, such as tetrahydrofuran.
- a dispersion of percent polyurethane in tetrahydrofuran was found particularly suitable. This was used to coat the compressed collagen foam film using a number 60 Meyer Rod to apply five coatings. The number of coatings could vary since the real control is obtaining the desired moisture vapor transmission rate. This rate will decrease as the plastic film is made thicker.
- Example 1 Dressing With Silver Starting with the collagen sold as Avitene by FMC Corporation, an equal parts blend of 25, 35, and 50 mesh collagen fibers are made into a 3.5 percent by weight aqueous dispersion containing 15 percent by volume petroleum ether, which immediately forms a gel. The fibers in the gel are subjected to attrition for 30 seconds at high speed in a Waring-blender. The dispersion of fibers still in the gel state is allowed to standfor one hour. The resultant gel is spread into a 50 mil thick wet film. This wet film is soaked in a 5 percent sodium bicarbonate solution containing 400 ppm glutaraldehyde for 1 hour, which makes the wet film porous.
- the bicarbonate neutralized porous collagen film is' then air dried.
- the dried film is rinsed with water for 1 hour and is then soaked in 20 percent glycerol for 15 minutes.
- the film is then force dried on a heated cam under slight pressure using a Bessler photographic dryer which used a coarse mesh nylon belt (in place of the usual cotton belt) to provide faster heat exchange.
- the dried film is soaked in Tollens reagent, Ag( NH OH, for 5 minutes, rinsed in water for 1 hour, and finally soaked in 20 percent glycerol for 15 minutes. It is then air dried.
- the resultant dried compressed tanned collagen foam film which is about 12-15 mils thick, is then coated 5 times (with air drying after each coat) with a dispersion of 20 percent Tuftane l 10 polyurethane in tetrahydrofuran using a No. Meyer rod, which resulted in the addition to the collagen layer of a polyurethane film about 3-5 mils thick. This was then dried.
- the resultant laminated film of polyurethane on a compressed foam collagen film has a moisture vapor transmission rate of about 3 mg/hr/cm
- the dressing was sterilized by being subjected to 2.5 megarods of cobalt irradiation and was then suitable for use as a surgical dressing, particularly for burns.
- the above dressing was tested on a Aminco Porosimeter and the collagen portion was found to have a porosity of 75.7 percent, of which 51 percent was from pores having pore diameters larger than 95.264 microns, and the other 24.7 percent was fairly well distributed among a very wide range of smaller pores, e.g. 6.3 percent was from pores ranging from 14.71 down to 10.13 microns, and there were 0.2 percent pores as small as 0.0160.013 microns. This indicates a welldistributed porous collagen structure with varying size pores.
- Example 2 Dressing Without Silver Example 1 was repeated except that no silver metal was impregnated in the collagen layer, i.e. the step of soaking in Tollens reagent was omitted.
- the resultant dressing was substantially identical to that of Example 1 except that it does not contain any silver.
- the bacteriostatic activity advantage of the silverimpregnated dressing of Example 1 over the non-silver dressing of Example 2 is unexpectedly high and is demonstrated dramatically by a zone of inhibition microbiological test procedure wherein a culture is made from beef serum containing some 6,000 viable cells of Pseudomonas aeruginosa, which has been incubated and placed on an agar plate, and 1 inch discs of the dressing of Example 1 and of the dressing of Example 2 are placed, collagen side down, on the surface of the agar.
- the zone of inhibition for the Example I silver-- containing dressing disc was 32.3 mm. while that for the Example 2 non-silver impregnated dressing disc was 0.
- the dressings of the present invention have been successfully evaluated on a number of different experimental animals.
- the dressings were evaluated on full thickness skin injuries using rats and rabbits. Dressings were applied and the healing response was observed over a 4-7 day period. The results indicated a wound bed suitable for grafting.
- the dressings of the present invention are elastic, pliable, flexible, soft, and have the ability when wet out to conform to the topography of the wound site.
- a pliable, surgical dressing especially useful in the treatment of burns comprising a thicker layer of a compressed, tanned collagen foam film and laminated to one surface of said compressed foam, a thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mglhr/cm 2.
- a pliable, surgical dressing especially useful in the treatment of burns comprising a thicker layer of compressed, tanned collagen foam film having silver metal impregnated therein and laminated to one surface of said compressed foam, an outer thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mg/hr/cm 5.
- the dressing of claim 4 wherein the amount of silver metal is from 0.5-1.5 mg silver per square inch of collagen film.
Abstract
A surgical dressing that is particularly useful for the treatment of burn wounds is disclosed made from a thicker layer of a collagen compressed foam film to which has been laminated, without any adhesive, a thin continuous layer of an inert polymer material, such as polyurethane, having a moisture vapor transmission rate slightly higher than that of human skin and which preferably also contains finely divided silver metal impregnated in the collagen layer.
Description
LAMINATED COLLAGEN FILM DRESSING Inventors: James J. McKnight, Martinsville;
Jack Guldalian, Jr., Laurence Twp., Mercer County, both of NJ.
[73] Assignee: Johnson & Johnson, New
Brunswick, NJ.
[22] Filed: Apr. 17, 1972 [21] Appl. No.: 244,439
[52] U.S. Cl 128/156, l28/DIG. 8, 260/114 [51] Int. Cl A611 15/00 [58] Field of Search 128/156, 334, DIG. 8; 260/114; 264/28 [56] References Cited UNITED STATES PATENTS 3,491,760 l/l970 Braum et al. 128/334 2,194,677 3/1940 Schneiderwirth 260/14 3,471,598 10/1969 Battista 264/28 3,628,974 12/1971 Battista 128/156 3,113,568 12/1963 Robins 128/156 Primary Examiner-Richard A. Gaudet Assistant Examiner-J. Yasko Attorney, Agent, or Firm-Herbert l. Sherman [57 ABSTRACT A surgical dressing thatv is particularly useful for the treatment of burn wounds is disclosed made from a thicker layer of a collagen compressed foam film to which has been laminated, without any adhesive, a thin continuous layer of an inert polymer material,
, such as polyurethane, having a moisture vapor transmission rate slightly higher than that of human skin and which preferably also contains finely divided silver metal impregnated in the collagen layer.
7 Claims, 3 Drawing Figures LAMINATED COLLAGEN FILM DRESSING BACKGROUND AND SUMMARY OF THE INVENTION In the treatment of severe burn wounds, i.e. second and third degree burn wounds, the patient passes through a number of different treatment phases. The first phase is to clean and stabilize the wound area and control the bacterial flora at the wound site. This treatment is carried out by debridement of the wound site, maintaining an electrolyte balance and by the topical application of antibacterial medications such as silver nitrate, silver sulfadiazine and other similar medications. The wound then passes through development of a granulation bed. Once this phase of the treatment is under control, the status quo of the wound site must be maintained awaiting autografting to complete the treatment. Since in many cases a period of time will pass before autografting is possible, the maintenance of the status quo wound site, i.e. the granulation bed, is an absolute necessity. The present methods used to maintain the status quo are by the repeated applications of wet gauze dressings or by employing a temporary homograft or heterograft. The repeated application of wet dressings is not particularly satisfactory as these dressings require frequent changes within any 24-hour period and tend to add to the discomfort of the patient. Homografts and heterografts have been found to be effective, but they are not readily available.
An object of the present invention is therefore to develop a material which can be considered a substitute for a homograft or a heterograft and which will maintain the wound site, i.e. the granulation bed, in a status quo condition until an autograft becomes feasible.
The requirements for a substitute homograft or heterograft, which the dressing of the present invention meets, are the following:
1. It should be a readily available material.
2. It should be capable of being applied to the wound site so as to completely isolate the wound site from the environment.
3. It must have sufficient strength to be secured over the wound area by sutures, clips, gauze, or with adhesive bandages.
4. It must be capable of being sterilized and easily stored.
5. It must have no antigenic properties.
6. It must have a moisture vapor transmission rate which will allow the proper moisture balance in the repairing wound, i.e. to prevent both hydration and dessication of the repairing tissue.
Moisture vapor transmission rate is the weight of water lost by evaporation through a film membrane at 37C over a period of 24 hours. The weight loss is determined using a Twing Albert permeability cap in a Blue M Electric Company Model POM-203A forced air oven at 37C. The weight loss is observed periodically over a 24 to 48 hour period. This moisture vapor transmission rate figure will vary if measured by other possible procedures, and all rates described herein are those measured by the above method.
It was formerly thought that this rate should be similar to that of human skin, i.e. about 1-1.5 milligrams per hour per centimeter squared, but we have learned that the rate should be slightly higher, i.e. about 2-7 milligrams per hour per centimeter squared mglhrlcm We have developed a simple dressing that meets these requirements. Our dressing is composed of a thicker layer (that which will be placed on the skin in actual use) of reconstituted collagen formed into a compressed tanned collagen foam film to which is laminated a thinner outer layer of an inert polymer plastic material, preferably polyurethane. A greatly preferred embodiment contains finely divided silver impregnated and distributed through the collagen layer.
Our new dressing can be 3-30 mils thick and is preferably about 18 mils thick. The dressing of our invention can have a moisture vapor transmission rate of from 2 to 7 mg/hr/cm and preferably has a rate of 3 mg/hr/cm.
DISCUSSION OF PRIOR ART Collagen in various forms has been used together with various other materials in the treatment of wounds and of burns. Braun, US. Pat. No. 3,491,760, discloses a skin used in heterotransplantation which is made from two different tanned collagen gel layers. The material is used to produce a heteroplastic skin by acting as a suitable nutrient medium. The layer next to the skin has a large-celled, foamy consistency (but is not a compressed foam), and it is covered by a collagen film which is very tough, elastic, and almost leathery to prevent the drying out of the first film. The patent-teaches v the optional cementing of an adhering plastic film, such as polyvinylchloride foil, over the leathery collagen film to prevent drying out of the collagen gel. The heteroplastic skin thus formed is fairly thick (the collagen foamy layer being well over mils thick and much thicker than that which applicants use). The various layers are cemented together with adhesives. A collagen foil dressing product that appears to be made by this method has been sold in Germany. This prior art dressing appears to have a moisture vapor transmission rate different from that of the instant invention.
Battista US. Pat. No. 3,471,598 discloses freeze drying a dispersion of a microcrystalline collagen to form a mat, which can be used in various applications including surgical dressings.
British Pat. No. 1,195,062, entitled Structures Comprising Microcrystalline Collagen and Methods of Forming Them,'discloses the use of microcrystalline colloidal dispersions and gels to produce films, which may then be applied to coat various types of fibers including fibers of various organic polymers such as polyurethane.
Schulte, US. Pat. No. 2,202,566, discloses the use of collagen fibers in a bandage.
Robbins, US. Pat. No. 3,113,568, discloses the use of a polyurethane foam in a special type of bandage.
None of the art specificallydiscloses the concept of the present invention of dressing made from a particular type of collagen formed into a layer of compressed collagen foam having laminated thereto a polyurethane film which has a moisture vapor transmission slightly higher than that of skin.
Reference is now made to the drawings wherein are set forth by way of illustration and examples certain embodiments of the present invention.
Referring to the drawings:
FIG. 1 is a plan view of a microphotograph showing the top 10 (i.e. the part away from the skin in actual use) of the surgical dressing of the present invention taken at 3,000 times magnification, and it shows the outer surface of the thinner polyurethane layer 12, which contains a great many microscopic pores 14.
FIG. 2 is an inverted plan view of a microphotograph showing the bottom 20 (i.e. the part which goes next to the skin in actual use) of the surgical dressing of the present invention taken at 10,000 times magnification, and it shows the outer. surface of the thicker compressed collagen foam 22, which contains a network of collagen fibers or fibrils 24 with pores or open spaces 26 between the collagen fibers or'fibrils.
FIG. 3 is a diagrammatic cross-section view on line 3-3 from FIG. 1 showing a side view through the center of the surgical dressing of the present invention. It shows the polyurethane layer laminated to the compressed collagen foam layer 20. Also visible in FIG. 3 are the pores 14 in the polyurethane, the collagen fibers 24 and the open spaces 26 between the collagen fibers, and the particles of silver metal 28 impregnated in the collagen foam 20.
THE STARTING COLLAGEN The compressed collagen foam film used in the surgical dressing of the instant invention may be made from collagen obtained from various sources as long as it has the necessary properties hereinafter described. Bovine collagen is the most common source. In particular, we have found satisfactory results may be obtained from a commercial product which is marketed by FMC Corporation under the trademark Avitene" or very small, fine, fluffy, collagen fiber particles which are relatively soft and not degraded, made as described in US. Pat. No. 3,471,598 and other patents assigned to FMC Corporation. Other usable collagen fibers are those used in the gels from which collagen sausage casings are extruded, which have been ground or milled to the smaller, fine, fiuffy sizes used here. Bovine hide-dried, ground, or milled-can also be used to make the gel from which the compressed foam of the present invention is made.
PREPARATION OF COLLAGEN GEL The starting collagen is separated into very fine, fluffy fibers (dry to feel and touch) on the order of 25, 35, and 50 mesh size. Avitene is sold as a dry fibrous blend of finely divided collagen fibers. These are screened through various sized sieves to separate the collagen into fibers of the same relative size on the order of 25-50 mesh. While specific size and mixtures of size is not critical and smaller or larger pieces of collagen could be used, we prefer to use equal parts of several different sizes, e.g. of 25, 35, and 50 mesh, blended together. The collagen fibers are then made into an aqueous dispersion with water, which dispersion contains about 3.5 percent by weight of said collagen fibers. The dispersion is homogenized and allowed to stand. The time of standing is not critical, but we have found 1 hour to be satisfactory. Then a fast evaporating organic solvent such as petroleum ether is added to the amount of about percent by volume. The purpose of using the organic solvent is to prevent complete selfbonding of the fibers in the reconstituted product. When Avitene collagen is used, the petroleum ether is added to the initial aqueous dispersion. Where a dry collagen other than Avitene has been used, the resultant blend is then acid swollen in the well known fashion (we prefer to use 0.8 percent by weight of lactic acid, but other acids or amounts should work also) and allowed to stand. Where Avitene is used, this step is omitted since the material is already in the acid state. The fibers are swollen by the action of the lactic acid and take up the liquid present in the dispersion to form a gel. The gel is preferably permitted to stand long enough to attain equilibrium, e.g. for an hour, before being used in the next step of the process.
PREPARATION OF COLLAGEN FOAM FILM The above gel, which contains acid swollen collagen, is spread into a thick wet film on the order of about 25 to mils, preferably 50 mils thick. The thickness of this thick wet gel film can vary, of course, depending on the desired thickness of the collagen layer in the desired end product dressing. It is next desired to impart further porosity to the collagen film so it will be somewhat foamy and also to tan (i.e. to cross-link) the collagen. Various foaming agents and tanning agents could be used. We prefer to soak the wet film in a 5 percent sodium bicarbonate solution which also contains 400 parts per million or more glutaraldehyde for a period of 1 hour. The glutaraldehyde is the tanning agent. The sodium bicarbonate is used to control the porosity of the film since it introduces uniform size gas bubbles while the acid swollen film is being neutralized with bicarbonate ions.
The resultant porous collagen film which has now been neutralized with bicarbonate, has had its constituent collagen deswollen so it now has a lesser thickness about one-half its former swollen size. It is then dried, e.g. by air drying. The resultant dried porous collagen film is well rinsed with water. We prefer a rinsing time of 1 hour. The water-rinsed film is then plasticized slightly. A suitable method is by soaking in 20 percent glycerol for 15 minutes.
Because the glutaraldehyde present in the sodium bicarbonate serves as a tanning agent (cross-linking agent), the dried film contains an excess of glutaraldehyde. The wet plasticized porous collagen film is dried and is also slightly compressed, i.e. to about onequarter of its original wet thickness (referring to the gel stage), for example, by being force dried on a heated cam under slight pressure. A typical thickness of the dried compressed collagen foam film at this point is about 12.5 mils.
The compressed collagen foam has been fairly well tanned so that it will not have antigenic activity. One method of determining the sufficiency of amount of tanning is by its resistance to collagenase attack. Here resistance to collagenase attack is assayed according to a procedure described by Mandl, I. in the J. Clinical lnvestigation, 32, I323 (1953). We have found that our cross-linked collagen is essentially resistant to hydrolysis by the enzyme collagenase from Cl. histolyticum. We have reduced the ability of the enzyme to attack the collagen by greater than percent.
ADDITION OF SILVER Where the preferred embodiment is desired, i.e. the use of a fine dispersion of silver throughout the collagen film, one way of adding it is by the use of Tollens reagent; e.g. the dried compressed foam collagen film can be soaked in Tollens reagent for 5 minutes. Tollens reagent, which has the formula Ag(NH Ol-l, is a reducing agent for aldehyde groups, and it serves to oxidize the excess glutaraldehyde and also to deposit silver metal on the accessible surfaces of the collagen fibers throughout the film. The specific amount of silver deposited or impregnated is that which is equivalent to the amount of excess aldehyde which has been oxidized to carboxyl. The silver acts as an antibacterial agent and is especially effective in amounts of from 1.5 mg silver per square inch to 0.5 mg silver per square inch when applied and impregnated in the manner herein suggested.
The collagen film, after being soaked in Tollens reagent for 5 minutes, is then rinsed in water for about an hour and finally plasticized, e.g. by being soaked in 20 percent glycerol for minutes, and it is then air dried.
While there can be a fair amount of variation, a typical compressed collagen foam film formed at this point might have a density of 1.8285 grams per cubic centimeter, a porosity of 76.4 percent, and a measured pore volume of 0.608 cubic centimeters per gram (as determined in the well-known manner on a Porosimeter, the particular machine being that manufactured by the American Instrument Company as their Aminco Digital Readout Porosimeter, 15,000 PSI Motor Driven).
LAMINATION TO THIN PLASTIC FILM The plasticized compressed collagen foam film is now ready to be coated with a plasticfilm. While it is physically possible to utilize various adhesives to attach the plastic film to the collagen film, animal tests have shown the resultant dressing to be unsatisfactory since they delaminated in actual use, wherefore the plastic film used in the present invention is laminated to the collagen film without any adhesive. While this can be accomplished various ways, we have found solvent casting to be quite satisfactory, i.e. dissolving the plastic in a solvent and then cast coating the collagen film with the dissolved plastic. The plastic we prefer is polyurethane, although other plastics ought work provided they give the desired moisture vapor transmission rates (slightly higher than that of skin) and do not release toxic or irritant chemiclas to the wound bed. The particular preferred polyurethane is a thermoplastic polyurethane sold by the B. F. Goodrich Chemical Company as Tuftane packaging film and which has high elongation and excellent stretch recovery properties as well as good strength and toughness. We have used their Tuftane No. 1 1O film in 1.0 mil thickness and dissolved it in an organic solvent, such as tetrahydrofuran. A dispersion of percent polyurethane in tetrahydrofuran was found particularly suitable. This was used to coat the compressed collagen foam film using a number 60 Meyer Rod to apply five coatings. The number of coatings could vary since the real control is obtaining the desired moisture vapor transmission rate. This rate will decrease as the plastic film is made thicker.
Naturally the dressing should be sterilized before use. Cobalt irradiation is the method of choice, but other methods could be used also.
Typical examples of dressings of this invention such as illustrated in the drawings and their construction are as follows.
Example 1 Dressing With Silver Starting with the collagen sold as Avitene by FMC Corporation, an equal parts blend of 25, 35, and 50 mesh collagen fibers are made into a 3.5 percent by weight aqueous dispersion containing 15 percent by volume petroleum ether, which immediately forms a gel. The fibers in the gel are subjected to attrition for 30 seconds at high speed in a Waring-blender. The dispersion of fibers still in the gel state is allowed to standfor one hour. The resultant gel is spread into a 50 mil thick wet film. This wet film is soaked in a 5 percent sodium bicarbonate solution containing 400 ppm glutaraldehyde for 1 hour, which makes the wet film porous. The bicarbonate neutralized porous collagen film is' then air dried. The dried film is rinsed with water for 1 hour and is then soaked in 20 percent glycerol for 15 minutes. The film is then force dried on a heated cam under slight pressure using a Bessler photographic dryer which used a coarse mesh nylon belt (in place of the usual cotton belt) to provide faster heat exchange. The dried film is soaked in Tollens reagent, Ag( NH OH, for 5 minutes, rinsed in water for 1 hour, and finally soaked in 20 percent glycerol for 15 minutes. It is then air dried. The resultant dried compressed tanned collagen foam film, which is about 12-15 mils thick, is then coated 5 times (with air drying after each coat) with a dispersion of 20 percent Tuftane l 10 polyurethane in tetrahydrofuran using a No. Meyer rod, which resulted in the addition to the collagen layer of a polyurethane film about 3-5 mils thick. This was then dried. The resultant laminated film of polyurethane on a compressed foam collagen film has a moisture vapor transmission rate of about 3 mg/hr/cm The dressing was sterilized by being subjected to 2.5 megarods of cobalt irradiation and was then suitable for use as a surgical dressing, particularly for burns.
The above dressing was tested on a Aminco Porosimeter and the collagen portion was found to have a porosity of 75.7 percent, of which 51 percent was from pores having pore diameters larger than 95.264 microns, and the other 24.7 percent was fairly well distributed among a very wide range of smaller pores, e.g. 6.3 percent was from pores ranging from 14.71 down to 10.13 microns, and there were 0.2 percent pores as small as 0.0160.013 microns. This indicates a welldistributed porous collagen structure with varying size pores.
Example 2 Dressing Without Silver Example 1 was repeated except that no silver metal was impregnated in the collagen layer, i.e. the step of soaking in Tollens reagent was omitted. The resultant dressing was substantially identical to that of Example 1 except that it does not contain any silver.
The bacteriostatic activity advantage of the silverimpregnated dressing of Example 1 over the non-silver dressing of Example 2 is unexpectedly high and is demonstrated dramatically by a zone of inhibition microbiological test procedure wherein a culture is made from beef serum containing some 6,000 viable cells of Pseudomonas aeruginosa, which has been incubated and placed on an agar plate, and 1 inch discs of the dressing of Example 1 and of the dressing of Example 2 are placed, collagen side down, on the surface of the agar. The zone of inhibition for the Example I silver-- containing dressing disc was 32.3 mm. while that for the Example 2 non-silver impregnated dressing disc was 0.
RELATED UNSUCCESSFUL PRODUCTS Similar materials to those used in the dressing of our invention have been used by us in dressings made by different constructions, for example, through the use of adhesives, and these have failed because of delamination in animal tests. Collagen films have also been made by us as dense continuous sheets which were de-aired in the gel state before they were cast into a film and so lacked the porosity of the present collagen film. These nonporous collagen films failed in critical tests on certain species of experimental animals although they appeared satisfactory on other species of animals.
The dressings of the present invention have been successfully evaluated on a number of different experimental animals. The dressings were evaluated on full thickness skin injuries using rats and rabbits. Dressings were applied and the healing response was observed over a 4-7 day period. The results indicated a wound bed suitable for grafting.
The dressings of the present invention are elastic, pliable, flexible, soft, and have the ability when wet out to conform to the topography of the wound site.
Particular embodiments of the invention have been used to illustrate the same. The invention, however, is not limited to these specific embodiments. In view of the foregoing disclosure, variations or modifications thereof will be apparent, and it is intended to include within the invention all such variations and modifications except as do not come within the scope of the appended claims.
We claim:
. l. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of a compressed, tanned collagen foam film and laminated to one surface of said compressed foam, a thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mglhr/cm 2. The dressing of claim 1 wherein the plastic film is polyurethane.
3. The dressing 'of claim 1 wherein the compressed collagen foam layer is 3-30 mils thick.
4. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of compressed, tanned collagen foam film having silver metal impregnated therein and laminated to one surface of said compressed foam, an outer thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mg/hr/cm 5. The dressing of claim 4 wherein the plastic film is polyurethane.
6. The dressing of claim 4 wherein the amount of silver metal is from 0.5-1.5 mg silver per square inch of collagen film.
7. The dressing of claim 4 wherein the compressed collagen foam layer is 3-30 mils thick.
Claims (6)
- 2. The dressing of claim 1 wherein the plastic film is polyurethane.
- 3. The dressing of claim 1 wherein the compressed collagen foam layer is 3-30 mils thick.
- 4. A pliable, surgical dressing especially useful in the treatment of burns, comprising a thicker layer of compressed, tanned collagen foam film having silver metal impregnated therein and laminated to one surface of said compressed foam, an outer thinner layer of plastic film having a moisture vapor transmission rate from 2-7 mg/hr/cm2.
- 5. The dressing of claim 4 wherein the plastic film is polyurethane.
- 6. The dressing of claim 4 wherein the amount of silver metal is from 0.5-1.5 mg silver per square inch of collagen film.
- 7. The dressing of claim 4 wherein the compressed collagen foam layer is 3-30 mils thick.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24443972A | 1972-04-17 | 1972-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3800792A true US3800792A (en) | 1974-04-02 |
Family
ID=22922775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00244439A Expired - Lifetime US3800792A (en) | 1972-04-17 | 1972-04-17 | Laminated collagen film dressing |
Country Status (1)
Country | Link |
---|---|
US (1) | US3800792A (en) |
Cited By (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896802A (en) * | 1974-04-19 | 1975-07-29 | American Cyanamid Co | Flexible flocked dressing |
US3903882A (en) * | 1974-04-19 | 1975-09-09 | American Cyanamid Co | Composite dressing |
US3949742A (en) * | 1974-09-20 | 1976-04-13 | Frigitronics, Inc. | Medical dressing |
FR2332863A1 (en) * | 1975-07-15 | 1977-06-24 | Massachusetts Inst Technology | MULTI-LAYER MEMBRANE USEFUL AS A SYNTHETIC SKIN |
EP0006714A1 (en) * | 1978-06-29 | 1980-01-09 | Johnson & Johnson | Balanced environment wound dressing |
US4233969A (en) * | 1976-11-11 | 1980-11-18 | Lock Peter M | Wound dressing materials |
US4306563A (en) * | 1979-11-28 | 1981-12-22 | Firma Pfrimmer & Co. Pharmazeutische Werke Erlangen Gmbh | Catheter for introduction into body cavities |
FR2503561A1 (en) * | 1981-04-13 | 1982-10-15 | Seton Co | CONTINUOUS FLEXIBLE FILM FOR COSMETIC AND PHARMACEUTICAL USE CONTAINING POLYPEPTIDES |
EP0068777A2 (en) * | 1981-06-26 | 1983-01-05 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
FR2524304A1 (en) * | 1982-03-31 | 1983-10-07 | Delalande Sa | ARTIFICIAL SKIN |
JPS59181158A (en) * | 1983-03-30 | 1984-10-15 | 日東電工株式会社 | Wound cover agent |
US4505266A (en) * | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
JPS6072557A (en) * | 1983-09-27 | 1985-04-24 | 日東電工株式会社 | Wound cover agent |
US4554317A (en) * | 1982-04-06 | 1985-11-19 | David Behar | Synthetic wound covering |
EP0167828A1 (en) * | 1984-06-11 | 1986-01-15 | Koken Co. Ltd. | A man-made skin composed of two layers:Collagen and a poly-alpha-amino acid |
EP0227955A2 (en) * | 1982-07-21 | 1987-07-08 | University of Strathclyde | Composite wound dressing |
US4703108A (en) * | 1984-03-27 | 1987-10-27 | University Of Medicine & Dentistry Of New Jersey | Biodegradable matrix and methods for producing same |
US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
US4759354A (en) * | 1986-11-26 | 1988-07-26 | The Kendall Company | Wound dressing |
US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
US4846164A (en) * | 1987-08-07 | 1989-07-11 | Martz Joel D | Vapor permeable dressing |
US4847049A (en) * | 1985-12-18 | 1989-07-11 | Vitaphore Corporation | Method of forming chelated collagen having bactericidal properties |
EP0371736A2 (en) * | 1988-11-29 | 1990-06-06 | Mitsubishi Kasei Corporation | Wound covering |
US4991574A (en) * | 1987-07-22 | 1991-02-12 | Dow Corning Corporation | Surgical dressing |
US4997425A (en) * | 1986-10-31 | 1991-03-05 | Nippon Zeon Co., Ltd. | Wound dressing |
EP0422046A1 (en) * | 1988-05-16 | 1991-04-17 | Kensey Nash Corp | Device for sealing percutaneous puncture in a vessel. |
EP0431479A1 (en) * | 1989-12-05 | 1991-06-12 | Hoechst Japan Limited | Wound surface-covering sheets |
US5061258A (en) * | 1987-08-07 | 1991-10-29 | Martz Joel D | Vapor permeable dressing with releasable medication |
US5149469A (en) * | 1989-07-11 | 1992-09-22 | Nippon Zeon Co., Ltd. | Method of manufacturing a wound dressing |
US5196185A (en) * | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
DE4227681A1 (en) * | 1992-08-21 | 1994-02-24 | Becker & Co Naturinwerk | Wound covering material based on collagen fibers |
EP0653214A1 (en) * | 1993-11-11 | 1995-05-17 | YISSUM RESEARCH DEVELOPMENT COMPANY of the Hebrew University of Jerusalem | Topical antibacterial preparation |
EP0666082A1 (en) * | 1994-02-04 | 1995-08-09 | Pharmalett International B.V. | Laminate for treating wounds |
US5516395A (en) * | 1988-09-22 | 1996-05-14 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene |
US5554106A (en) * | 1994-10-13 | 1996-09-10 | Quinton Instrument Company | Hydrocolloid exit site dressing |
US5569207A (en) * | 1994-10-13 | 1996-10-29 | Quinton Instrument Company | Hydrocolloid dressing |
US5593395A (en) * | 1987-08-07 | 1997-01-14 | Martz; Joel D. | Vapor permeable dressing |
US5676967A (en) * | 1995-04-18 | 1997-10-14 | Brennen Medical, Inc. | Mesh matrix wound dressing |
US5709934A (en) * | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
US5814094A (en) * | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
US5814328A (en) * | 1997-01-13 | 1998-09-29 | Gunasekaran; Subramanian | Preparation of collagen using papain and a reducing agent |
US5868778A (en) * | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
US5957952A (en) * | 1993-05-25 | 1999-09-28 | Vascular Solutions, Inc. | Vascular sealing device |
US6007563A (en) * | 1991-11-08 | 1999-12-28 | Kensey Nash Corporation | Method of deploying percutaneous puncture closure |
US6017359A (en) * | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US6080490A (en) * | 1990-12-24 | 2000-06-27 | Westaim Technologies Inc. | Actively sterile surfaces |
US6103369A (en) * | 1989-12-29 | 2000-08-15 | 3M Innovative Properties Company | Multi-layered dressing |
US20020013300A1 (en) * | 2000-03-17 | 2002-01-31 | Avocet Polymer Technologies, Inc. | Methods for improving size and appearance of a wound |
US20020028243A1 (en) * | 1998-09-25 | 2002-03-07 | Masters David B. | Protein matrix materials, devices and methods of making and using thereof |
US6365220B1 (en) | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
US20020173806A1 (en) * | 1996-08-30 | 2002-11-21 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US20030007991A1 (en) * | 1998-09-25 | 2003-01-09 | Masters David B. | Devices including protein matrix materials and methods of making and using thereof |
US20030021854A1 (en) * | 2001-04-23 | 2003-01-30 | Burrell Robert Edward | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
WO2003047643A1 (en) * | 2001-12-06 | 2003-06-12 | Johnson & Johnson Medical Limited | Controlled release therapeutic wound dressings |
US6582713B2 (en) | 2000-04-06 | 2003-06-24 | Univ. Of Colorado - Colorado Springs | Compositions and methods for promoting wound healing |
US20030180378A1 (en) * | 2000-07-27 | 2003-09-25 | Gillis Scott H. | Dry powders of metal-containing compounds |
US20030203046A1 (en) * | 2000-07-27 | 2003-10-30 | Burrell Robert E. | Solutions and aerosols of metal-containing compounds |
US20030206966A1 (en) * | 2000-07-27 | 2003-11-06 | Burrell Robert E. | Methods of inducing apoptosis and modulating metalloproteinases |
US20030211793A1 (en) * | 2001-03-05 | 2003-11-13 | Eugene Bell | Injectable bio-compatible material and methods of use |
WO2003099230A2 (en) * | 2002-05-28 | 2003-12-04 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
US6680113B1 (en) | 1989-12-29 | 2004-01-20 | 3M Innovative Properties Company | Multi-layered dressing |
US20040030276A1 (en) * | 1997-09-22 | 2004-02-12 | Flick Bart A. | Conductive wound dressings and methods of use |
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US20040048796A1 (en) * | 2002-03-26 | 2004-03-11 | Hariri Robert J. | Collagen biofabric and methods of preparation and use therefor |
US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US20040131698A1 (en) * | 2000-07-27 | 2004-07-08 | Gillis Scott H. | Methods of treating conditions using metal-containing materials |
US20040129112A1 (en) * | 2000-07-27 | 2004-07-08 | Gillis Scott H. | Metal-containing materials |
US20040136968A1 (en) * | 2002-09-27 | 2004-07-15 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
US20040176312A1 (en) * | 2002-04-23 | 2004-09-09 | Gillis Scott H. | Treatment of ungual and subungual diseases |
US20040180093A1 (en) * | 2003-03-12 | 2004-09-16 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20040258738A1 (en) * | 2000-12-21 | 2004-12-23 | Kania Bruce G. | Treatment devices providing targeted antimicrobial action |
US20050123621A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
US20050124724A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20050123590A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Wound dressings and methods |
US20050147690A1 (en) * | 1998-09-25 | 2005-07-07 | Masters David B. | Biocompatible protein particles, particle devices and methods thereof |
US20050158364A1 (en) * | 2000-11-07 | 2005-07-21 | Cryolife, Inc. | Methods of making expandable foam-like biomaterials |
US20050163817A1 (en) * | 2002-04-29 | 2005-07-28 | Masters David B. | Biomatrix structural containment and fixation systems and methods of use thereof |
US20050196440A1 (en) * | 2003-12-08 | 2005-09-08 | Masters David B. | Mucoadhesive drug delivery devices and methods of making and using thereof |
US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
US20050283256A1 (en) * | 2004-02-09 | 2005-12-22 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
US20060004407A1 (en) * | 2004-02-17 | 2006-01-05 | Hiles Michael C | Medical devices and methods useful for applying bolster material |
US20060004314A1 (en) * | 2001-06-14 | 2006-01-05 | Hemcon, Inc. | Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan |
US20060025786A1 (en) * | 1996-08-30 | 2006-02-02 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US20060034899A1 (en) * | 2004-08-12 | 2006-02-16 | Ylitalo Caroline M | Biologically-active adhesive articles and methods of manufacture |
US20060035039A1 (en) * | 2004-08-12 | 2006-02-16 | 3M Innovative Properties Company | Silver-releasing articles and methods of manufacture |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US7041868B2 (en) | 2000-12-29 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | Bioabsorbable wound dressing |
US20060149040A1 (en) * | 2002-05-21 | 2006-07-06 | John Snowden | Collagen and method for producing same |
US20060167540A1 (en) * | 2003-06-17 | 2006-07-27 | Masters David B | Encapsulated or coated stent systems |
US20060173087A1 (en) * | 2003-03-12 | 2006-08-03 | Hyde Patrick D | Absorbent polymer compositions, medical articles, and methods |
US20060211973A1 (en) * | 2005-03-17 | 2006-09-21 | Gregory Kenton W | Systems and methods for hemorrhage control and or tissue repair |
US20060210960A1 (en) * | 1990-09-12 | 2006-09-21 | Lifecell Corporation, A Texas Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US20060233889A1 (en) * | 2005-04-14 | 2006-10-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
US20070014755A1 (en) * | 2005-07-01 | 2007-01-18 | Beckman Eric J | Wound healing polymeric networks |
US20070038298A1 (en) * | 2005-06-30 | 2007-02-15 | Sulner Joseph W | Repair of tympanic membrane using placenta derived collagen biofabric |
US20070073415A1 (en) * | 2005-09-29 | 2007-03-29 | Codman And Shurtleff, Inc. | Dural graft and method of preparing the same |
US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US20070166399A1 (en) * | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
US20080063694A1 (en) * | 2006-09-07 | 2008-03-13 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20080069895A1 (en) * | 2006-08-15 | 2008-03-20 | Qing Liu | Umbilical cord biomaterial for medical use |
US7358284B2 (en) | 1998-06-19 | 2008-04-15 | Lifecell Corporation | Particulate acellular tissue matrix |
US20080121592A1 (en) * | 2006-09-07 | 2008-05-29 | Biolargo Life Technologies, Incorporated | Systems and methods for cleaning liquid carriers related applications data |
US20080131522A1 (en) * | 2006-10-03 | 2008-06-05 | Qing Liu | Use of placental biomaterial for ocular surgery |
WO2008065329A2 (en) * | 2006-11-30 | 2008-06-05 | Systagenix Wound Management Ip Co. B.V. | Protein sheet material |
US20080146984A1 (en) * | 2002-06-14 | 2008-06-19 | Hemcon Medical Technologies, Inc. | Method for preparing a compressed wound dressing |
US20080146983A1 (en) * | 2006-12-19 | 2008-06-19 | Biopol Co., Ltd. | Polyurethane foam dressing with improved moisturization |
US20080181935A1 (en) * | 2006-10-06 | 2008-07-31 | Mohit Bhatia | Human placental collagen compositions, and methods of making and using the same |
US20080287907A1 (en) * | 2006-05-23 | 2008-11-20 | Providence Health System-Oregan D/B/A Providence St. Vincent Medical Center | Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
US20090018479A1 (en) * | 2002-06-14 | 2009-01-15 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan |
US20090028915A1 (en) * | 2006-09-07 | 2009-01-29 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20090069736A1 (en) * | 2002-10-29 | 2009-03-12 | Biopol Co., Ltd. | Polyurethane Foam Dressing for Wound Filler and Method for Manufacturing Thereof |
US7517536B2 (en) | 2005-11-25 | 2009-04-14 | Feng Chia University | Antimicrobial compositions and wound dressings |
US20090128716A1 (en) * | 2007-11-15 | 2009-05-21 | Funai Electric Co., Ltd. | Projector and method for projecting image |
US20090211693A1 (en) * | 2005-12-16 | 2009-08-27 | Molynlycke Health Care Ab | Method for perforating heat meltable material |
US20090269413A1 (en) * | 2008-04-23 | 2009-10-29 | Codman & Shurtleff, Inc. | Flowable collagen material for dural closure |
US20100098949A1 (en) * | 2006-10-18 | 2010-04-22 | Burton Scott A | Antimicrobial articles and method of manufacture |
US20100143487A1 (en) * | 2007-12-26 | 2010-06-10 | Gel-Del Technologies, Inc. | Biocompatible protein-based particles and methods thereof |
US20100172958A1 (en) * | 2008-05-02 | 2010-07-08 | Hemcon Medical Technologies, Inc. | Wound dressing devices and methods |
US20110034410A1 (en) * | 2002-06-14 | 2011-02-10 | Mccarthy Simon J | Wound dressing and method for controlling severe, life-threatening bleeding |
EP2315555A2 (en) * | 2008-08-07 | 2011-05-04 | Manuela Singer | Reusable medical protective clothing for pets and farm animals after surgeries and with skin diseases |
US20110104303A1 (en) * | 2006-09-07 | 2011-05-05 | Biolargo Life Technologies, Inc. | Material having antimicrobial activity when wet |
DE202011100392U1 (en) | 2011-05-07 | 2011-06-09 | Neubauer, Norbert, 38820 | Burns Edition |
AU2008229658B2 (en) * | 2002-04-23 | 2011-06-09 | Argentum International, Llc | Conductive wound dressings and methods of use |
US20110143312A1 (en) * | 2001-06-14 | 2011-06-16 | Hemcon Medical Technologies, Inc. | Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan |
US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
WO2013135478A1 (en) * | 2012-03-13 | 2013-09-19 | Aap Biomaterials Gmbh | Antibacterial sheet material that can be used as a wound dressing and method for producing same |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
US9089366B2 (en) | 2013-04-04 | 2015-07-28 | Steven Garner-Richards | System for tracking surgical objects |
US20160129151A1 (en) * | 2014-11-06 | 2016-05-12 | Case Western Reserve University | Protein based materials |
US9403953B2 (en) | 2011-07-06 | 2016-08-02 | Diversified Global Technologies, Llc | Cosmetic sponge and method for providing a cosmetic sponge |
US9849611B2 (en) | 2012-03-13 | 2017-12-26 | Aap Biomaterials Gmbh | Method for producing collagen-containing sheet material |
EP3360585A1 (en) | 2013-03-15 | 2018-08-15 | Celularity, Inc. | Improved method of making extracellular matrix compositions |
US10058455B2 (en) | 2013-06-10 | 2018-08-28 | Ultramend, Inc. | Nano-enhanced wound dressing |
US10086105B2 (en) | 2008-10-06 | 2018-10-02 | Providence Health System—Oregon | Chitosan foam medical devices and methods |
WO2019056819A1 (en) * | 2017-09-22 | 2019-03-28 | 青岛明月生物医用材料有限公司 | Collagen-loaded alginate medical dressing and preparation method therefor |
EP4285944A1 (en) * | 2022-06-01 | 2023-12-06 | MedSkin Solutions Dr. Suwelack AG | Method of making a composition with a film-coated porous material |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2194677A (en) * | 1938-12-19 | 1940-03-26 | Herman J Schneiderwirth | Silver animal mucin and process for producing same |
US2272728A (en) * | 1941-01-13 | 1942-02-10 | Rosenzweig Sam | Process for imparting bactericidal and sterilizing properties to natural sponges |
US2785154A (en) * | 1954-09-13 | 1957-03-12 | Crookes Barnes Lab Inc | Process of producing a stable silver protein composition |
US2785153A (en) * | 1954-09-13 | 1957-03-12 | Crookes Barnes Lab Inc | Silver protein |
US2858830A (en) * | 1956-10-01 | 1958-11-04 | Frank C Lowe | Surgical dressing |
US3113568A (en) * | 1961-12-26 | 1963-12-10 | Eric K Erskine | Styptic bandage |
US3471598A (en) * | 1966-02-14 | 1969-10-07 | Fmc Corp | Method of producing absorbent mats |
US3491760A (en) * | 1965-07-09 | 1970-01-27 | Braun Intern Gmbh B | Wound coverings |
GB1195062A (en) * | 1966-05-27 | 1970-06-17 | Fmc Corp | Structures comprising Microcrystalline Collagen and Methods of Forming them. |
US3628974A (en) * | 1966-05-27 | 1971-12-21 | Fmc Corp | Microcrystalline collagen, an ionizable partial salt of collagen and foods, pharmaceuticals and cosmetics containing same |
-
1972
- 1972-04-17 US US00244439A patent/US3800792A/en not_active Expired - Lifetime
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2194677A (en) * | 1938-12-19 | 1940-03-26 | Herman J Schneiderwirth | Silver animal mucin and process for producing same |
US2272728A (en) * | 1941-01-13 | 1942-02-10 | Rosenzweig Sam | Process for imparting bactericidal and sterilizing properties to natural sponges |
US2785154A (en) * | 1954-09-13 | 1957-03-12 | Crookes Barnes Lab Inc | Process of producing a stable silver protein composition |
US2785153A (en) * | 1954-09-13 | 1957-03-12 | Crookes Barnes Lab Inc | Silver protein |
US2858830A (en) * | 1956-10-01 | 1958-11-04 | Frank C Lowe | Surgical dressing |
US3113568A (en) * | 1961-12-26 | 1963-12-10 | Eric K Erskine | Styptic bandage |
US3491760A (en) * | 1965-07-09 | 1970-01-27 | Braun Intern Gmbh B | Wound coverings |
US3471598A (en) * | 1966-02-14 | 1969-10-07 | Fmc Corp | Method of producing absorbent mats |
GB1195062A (en) * | 1966-05-27 | 1970-06-17 | Fmc Corp | Structures comprising Microcrystalline Collagen and Methods of Forming them. |
US3628974A (en) * | 1966-05-27 | 1971-12-21 | Fmc Corp | Microcrystalline collagen, an ionizable partial salt of collagen and foods, pharmaceuticals and cosmetics containing same |
Cited By (259)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896802A (en) * | 1974-04-19 | 1975-07-29 | American Cyanamid Co | Flexible flocked dressing |
US3903882A (en) * | 1974-04-19 | 1975-09-09 | American Cyanamid Co | Composite dressing |
US3949742A (en) * | 1974-09-20 | 1976-04-13 | Frigitronics, Inc. | Medical dressing |
US4060081A (en) * | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
FR2332863A1 (en) * | 1975-07-15 | 1977-06-24 | Massachusetts Inst Technology | MULTI-LAYER MEMBRANE USEFUL AS A SYNTHETIC SKIN |
US4233969A (en) * | 1976-11-11 | 1980-11-18 | Lock Peter M | Wound dressing materials |
EP0006714A1 (en) * | 1978-06-29 | 1980-01-09 | Johnson & Johnson | Balanced environment wound dressing |
US4306563A (en) * | 1979-11-28 | 1981-12-22 | Firma Pfrimmer & Co. Pharmazeutische Werke Erlangen Gmbh | Catheter for introduction into body cavities |
FR2503561A1 (en) * | 1981-04-13 | 1982-10-15 | Seton Co | CONTINUOUS FLEXIBLE FILM FOR COSMETIC AND PHARMACEUTICAL USE CONTAINING POLYPEPTIDES |
EP0068777A2 (en) * | 1981-06-26 | 1983-01-05 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
EP0068777A3 (en) * | 1981-06-26 | 1983-06-29 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4505266A (en) * | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
FR2524304A1 (en) * | 1982-03-31 | 1983-10-07 | Delalande Sa | ARTIFICIAL SKIN |
US4554317A (en) * | 1982-04-06 | 1985-11-19 | David Behar | Synthetic wound covering |
EP0227955A2 (en) * | 1982-07-21 | 1987-07-08 | University of Strathclyde | Composite wound dressing |
EP0227955A3 (en) * | 1982-07-21 | 1987-11-25 | University of Strathclyde | Composite wound dressing |
JPS59181158A (en) * | 1983-03-30 | 1984-10-15 | 日東電工株式会社 | Wound cover agent |
JPS6346702B2 (en) * | 1983-03-30 | 1988-09-16 | Nitto Electric Ind Co | |
JPS6072557A (en) * | 1983-09-27 | 1985-04-24 | 日東電工株式会社 | Wound cover agent |
JPS6340543B2 (en) * | 1983-09-27 | 1988-08-11 | Nitto Electric Ind Co | |
US4703108A (en) * | 1984-03-27 | 1987-10-27 | University Of Medicine & Dentistry Of New Jersey | Biodegradable matrix and methods for producing same |
US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
EP0167828A1 (en) * | 1984-06-11 | 1986-01-15 | Koken Co. Ltd. | A man-made skin composed of two layers:Collagen and a poly-alpha-amino acid |
US4847049A (en) * | 1985-12-18 | 1989-07-11 | Vitaphore Corporation | Method of forming chelated collagen having bactericidal properties |
US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
US4997425A (en) * | 1986-10-31 | 1991-03-05 | Nippon Zeon Co., Ltd. | Wound dressing |
US4759354A (en) * | 1986-11-26 | 1988-07-26 | The Kendall Company | Wound dressing |
US4991574A (en) * | 1987-07-22 | 1991-02-12 | Dow Corning Corporation | Surgical dressing |
US4846164A (en) * | 1987-08-07 | 1989-07-11 | Martz Joel D | Vapor permeable dressing |
US5593395A (en) * | 1987-08-07 | 1997-01-14 | Martz; Joel D. | Vapor permeable dressing |
US5061258A (en) * | 1987-08-07 | 1991-10-29 | Martz Joel D | Vapor permeable dressing with releasable medication |
EP0422046A4 (en) * | 1988-05-16 | 1991-06-19 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
EP0422046A1 (en) * | 1988-05-16 | 1991-04-17 | Kensey Nash Corp | Device for sealing percutaneous puncture in a vessel. |
US5516395A (en) * | 1988-09-22 | 1996-05-14 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene |
EP0371736A3 (en) * | 1988-11-29 | 1990-12-27 | Mitsubishi Kasei Corporation | Wound covering |
EP0371736A2 (en) * | 1988-11-29 | 1990-06-06 | Mitsubishi Kasei Corporation | Wound covering |
US5149469A (en) * | 1989-07-11 | 1992-09-22 | Nippon Zeon Co., Ltd. | Method of manufacturing a wound dressing |
US5298015A (en) * | 1989-07-11 | 1994-03-29 | Nippon Zeon Co., Ltd. | Wound dressing having a porous structure |
US5196185A (en) * | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
EP0431479A1 (en) * | 1989-12-05 | 1991-06-12 | Hoechst Japan Limited | Wound surface-covering sheets |
US6680113B1 (en) | 1989-12-29 | 2004-01-20 | 3M Innovative Properties Company | Multi-layered dressing |
US6103369A (en) * | 1989-12-29 | 2000-08-15 | 3M Innovative Properties Company | Multi-layered dressing |
US20060210960A1 (en) * | 1990-09-12 | 2006-09-21 | Lifecell Corporation, A Texas Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US6080490A (en) * | 1990-12-24 | 2000-06-27 | Westaim Technologies Inc. | Actively sterile surfaces |
US6007563A (en) * | 1991-11-08 | 1999-12-28 | Kensey Nash Corporation | Method of deploying percutaneous puncture closure |
DE4227681A1 (en) * | 1992-08-21 | 1994-02-24 | Becker & Co Naturinwerk | Wound covering material based on collagen fibers |
US6022557A (en) * | 1992-08-21 | 2000-02-08 | Naturin Gmbh & Co. | Material on the basis of collagen fibers for covering wounds |
US6017359A (en) * | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US6296658B1 (en) | 1993-05-25 | 2001-10-02 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US5957952A (en) * | 1993-05-25 | 1999-09-28 | Vascular Solutions, Inc. | Vascular sealing device |
EP0653214A1 (en) * | 1993-11-11 | 1995-05-17 | YISSUM RESEARCH DEVELOPMENT COMPANY of the Hebrew University of Jerusalem | Topical antibacterial preparation |
US5514657A (en) * | 1993-11-11 | 1996-05-07 | Yissum Research Development Company Of The Hebrew University | Topical antibacterial preparation |
EP0666082A1 (en) * | 1994-02-04 | 1995-08-09 | Pharmalett International B.V. | Laminate for treating wounds |
US5554106A (en) * | 1994-10-13 | 1996-09-10 | Quinton Instrument Company | Hydrocolloid exit site dressing |
US5569207A (en) * | 1994-10-13 | 1996-10-29 | Quinton Instrument Company | Hydrocolloid dressing |
US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
US5709934A (en) * | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
US5948429A (en) * | 1994-11-22 | 1999-09-07 | Tissue Engineering, Inc. | Methods for preparing biopolymer foams |
US6153292A (en) * | 1994-11-22 | 2000-11-28 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
US5676967A (en) * | 1995-04-18 | 1997-10-14 | Brennen Medical, Inc. | Mesh matrix wound dressing |
US8293964B2 (en) | 1995-09-05 | 2012-10-23 | Argentum Medical, Llc | Multilayer laminate wound dressing |
US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
US8118791B2 (en) | 1995-09-05 | 2012-02-21 | Argentum Medical, Llc | Medical device |
US20080114279A1 (en) * | 1995-09-05 | 2008-05-15 | Argentum Medical, Llc | Multilayer laminate wound dressing |
US8283513B2 (en) | 1995-09-05 | 2012-10-09 | Argentum Medical, Llc | Multilayer wound dressing |
US7005556B1 (en) | 1995-09-05 | 2006-02-28 | Argentum Medical | Multilayer wound dressing |
US20070179522A1 (en) * | 1995-09-05 | 2007-08-02 | Argentum Medical, Llc | Multilayer wound dressing |
US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
US5868778A (en) * | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US5814094A (en) * | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
US20060025786A1 (en) * | 1996-08-30 | 2006-02-02 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US20020173806A1 (en) * | 1996-08-30 | 2002-11-21 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US6548077B1 (en) | 1997-01-13 | 2003-04-15 | Subramanian Gunasekaran | Purifying type I collagen using two papain treatments and reducing and delipidation agents |
US5814328A (en) * | 1997-01-13 | 1998-09-29 | Gunasekaran; Subramanian | Preparation of collagen using papain and a reducing agent |
US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US7291762B2 (en) | 1997-09-22 | 2007-11-06 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US20040030276A1 (en) * | 1997-09-22 | 2004-02-12 | Flick Bart A. | Conductive wound dressings and methods of use |
EP1864634A2 (en) | 1997-09-22 | 2007-12-12 | Argentum International, LLC | Multilayer conductive appliance having wound healing and analgesic properties |
US8455710B2 (en) * | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
US8449514B2 (en) | 1997-09-22 | 2013-05-28 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US7230153B2 (en) | 1997-09-22 | 2007-06-12 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US20080033506A1 (en) * | 1997-09-22 | 2008-02-07 | Argentum International, Llc | Multilayer Conductive Appliance Having Wound Healing and Analgesic Properties |
EP2316524A1 (en) | 1997-09-22 | 2011-05-04 | Argentum International, LLC | Multilayer conductive appliance having wound healing and analgesic properties |
US8093444B2 (en) | 1997-09-22 | 2012-01-10 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US7989674B2 (en) | 1997-09-22 | 2011-08-02 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
US6365220B1 (en) | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
US7358284B2 (en) | 1998-06-19 | 2008-04-15 | Lifecell Corporation | Particulate acellular tissue matrix |
US20100196478A1 (en) * | 1998-09-25 | 2010-08-05 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US7662409B2 (en) | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US20050147690A1 (en) * | 1998-09-25 | 2005-07-07 | Masters David B. | Biocompatible protein particles, particle devices and methods thereof |
US20020028243A1 (en) * | 1998-09-25 | 2002-03-07 | Masters David B. | Protein matrix materials, devices and methods of making and using thereof |
US20030007991A1 (en) * | 1998-09-25 | 2003-01-09 | Masters David B. | Devices including protein matrix materials and methods of making and using thereof |
US8871267B2 (en) | 1998-09-25 | 2014-10-28 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
US20070010778A1 (en) * | 2000-03-13 | 2007-01-11 | Nucryst Pharmaceuticals Corp., A Canadian Corporation | Transcutaneous medical device dressings and method of use |
US20020013300A1 (en) * | 2000-03-17 | 2002-01-31 | Avocet Polymer Technologies, Inc. | Methods for improving size and appearance of a wound |
US6582713B2 (en) | 2000-04-06 | 2003-06-24 | Univ. Of Colorado - Colorado Springs | Compositions and methods for promoting wound healing |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US20030180378A1 (en) * | 2000-07-27 | 2003-09-25 | Gillis Scott H. | Dry powders of metal-containing compounds |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US20030206966A1 (en) * | 2000-07-27 | 2003-11-06 | Burrell Robert E. | Methods of inducing apoptosis and modulating metalloproteinases |
US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
US20030203046A1 (en) * | 2000-07-27 | 2003-10-30 | Burrell Robert E. | Solutions and aerosols of metal-containing compounds |
US20080014286A1 (en) * | 2000-07-27 | 2008-01-17 | Nucryst Pharmaceuticals Corp., A Canada Corporation | Metal-containing materials |
US20040131698A1 (en) * | 2000-07-27 | 2004-07-08 | Gillis Scott H. | Methods of treating conditions using metal-containing materials |
US20040129112A1 (en) * | 2000-07-27 | 2004-07-08 | Gillis Scott H. | Metal-containing materials |
US7078060B2 (en) | 2000-07-27 | 2006-07-18 | Nucryst Pharmaceuticals Corp. | Solutions and aerosols of metal-containing compounds |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
US8057818B2 (en) * | 2000-11-07 | 2011-11-15 | Cryolife, Inc. | Methods of making expandable foam-like biomaterials |
US20050158364A1 (en) * | 2000-11-07 | 2005-07-21 | Cryolife, Inc. | Methods of making expandable foam-like biomaterials |
US20050163819A1 (en) * | 2000-11-07 | 2005-07-28 | Cryolife, Inc | Methods of using expandable foam-like biomaterials |
US8071124B2 (en) * | 2000-11-07 | 2011-12-06 | Cryolife, Inc. | Methods of using expandable foam-like biomaterials |
US7157614B1 (en) | 2000-12-21 | 2007-01-02 | Fountainhead, Llc | Treatment devices providing targeted antimicrobial action |
US20040258738A1 (en) * | 2000-12-21 | 2004-12-23 | Kania Bruce G. | Treatment devices providing targeted antimicrobial action |
US7041868B2 (en) | 2000-12-29 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | Bioabsorbable wound dressing |
US20030211793A1 (en) * | 2001-03-05 | 2003-11-13 | Eugene Bell | Injectable bio-compatible material and methods of use |
US6723350B2 (en) | 2001-04-23 | 2004-04-20 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
US20060204591A1 (en) * | 2001-04-23 | 2006-09-14 | Nucryst Pharamaceuticals Corp., A Canadian Corporation | Treatment of mucosal membranes |
US20060083777A1 (en) * | 2001-04-23 | 2006-04-20 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US20060083792A1 (en) * | 2001-04-23 | 2006-04-20 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
US6939568B2 (en) | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
US20030021854A1 (en) * | 2001-04-23 | 2003-01-30 | Burrell Robert Edward | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US7087249B2 (en) | 2001-04-23 | 2006-08-08 | Nucryst Pharmaceuticals Corp. | Treatment of mucosal membranes |
US9004918B2 (en) | 2001-06-14 | 2015-04-14 | Hemcon Medical Technologies, Inc. | Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan |
US20110143312A1 (en) * | 2001-06-14 | 2011-06-16 | Hemcon Medical Technologies, Inc. | Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan |
US9132206B2 (en) | 2001-06-14 | 2015-09-15 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
US20060004314A1 (en) * | 2001-06-14 | 2006-01-05 | Hemcon, Inc. | Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan |
EP1435911A1 (en) * | 2001-08-03 | 2004-07-14 | Gel-Del Technologies, Inc. | Devices including protein matrix materials and methods of making and using same |
EP1435911A4 (en) * | 2001-08-03 | 2010-03-24 | Gel Del Technologies Inc | Devices including protein matrix materials and methods of making and using same |
WO2003047643A1 (en) * | 2001-12-06 | 2003-06-12 | Johnson & Johnson Medical Limited | Controlled release therapeutic wound dressings |
US20050159695A1 (en) * | 2001-12-06 | 2005-07-21 | Cullen Breda M. | Controlled release therapeutic wound dressings |
US7732655B2 (en) | 2001-12-06 | 2010-06-08 | Systagenix Wound Management (Us), Inc. | Controlled release therapeutic wound dressings |
EP2702871A1 (en) | 2002-03-26 | 2014-03-05 | Anthrogenesis Corporation | Collagen biofabric and methods of preparation and use therefor |
EP2700309A1 (en) | 2002-03-26 | 2014-02-26 | Anthrogenesis Corporation | Collagen biofabric and methods of preparation and use therefor |
EP3412322A1 (en) | 2002-03-26 | 2018-12-12 | Celularity, Inc. | Collagen biofabric and methods of preparation and use therefor |
US20040048796A1 (en) * | 2002-03-26 | 2004-03-11 | Hariri Robert J. | Collagen biofabric and methods of preparation and use therefor |
AU2008229658B2 (en) * | 2002-04-23 | 2011-06-09 | Argentum International, Llc | Conductive wound dressings and methods of use |
US20040176312A1 (en) * | 2002-04-23 | 2004-09-09 | Gillis Scott H. | Treatment of ungual and subungual diseases |
US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
US20050163817A1 (en) * | 2002-04-29 | 2005-07-28 | Masters David B. | Biomatrix structural containment and fixation systems and methods of use thereof |
US8623393B2 (en) | 2002-04-29 | 2014-01-07 | Gel-Del Technologies, Inc. | Biomatrix structural containment and fixation systems and methods of use thereof |
US20060149040A1 (en) * | 2002-05-21 | 2006-07-06 | John Snowden | Collagen and method for producing same |
WO2003099230A3 (en) * | 2002-05-28 | 2004-06-10 | Univ Virginia Commonwealth | Electroprocessed collagen and tissue engineering |
WO2003099230A2 (en) * | 2002-05-28 | 2003-12-04 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
US8269058B2 (en) | 2002-06-14 | 2012-09-18 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
US20080146984A1 (en) * | 2002-06-14 | 2008-06-19 | Hemcon Medical Technologies, Inc. | Method for preparing a compressed wound dressing |
US20110034410A1 (en) * | 2002-06-14 | 2011-02-10 | Mccarthy Simon J | Wound dressing and method for controlling severe, life-threatening bleeding |
US8313474B2 (en) | 2002-06-14 | 2012-11-20 | Hemcon Medical Technologies, Inc. | Method for preparing a compressed wound dressing |
US8668924B2 (en) | 2002-06-14 | 2014-03-11 | Providence Health System—Oregon | Wound dressing and method for controlling severe, life-threatening bleeding |
US20090018479A1 (en) * | 2002-06-14 | 2009-01-15 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan |
US20040136968A1 (en) * | 2002-09-27 | 2004-07-15 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
US20070212396A1 (en) * | 2002-09-27 | 2007-09-13 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
US20090069736A1 (en) * | 2002-10-29 | 2009-03-12 | Biopol Co., Ltd. | Polyurethane Foam Dressing for Wound Filler and Method for Manufacturing Thereof |
US7777090B2 (en) | 2002-10-29 | 2010-08-17 | Biopol Co., Ltd. | Polyurethane foam dressing for wound filler and method for manufacturing thereof |
US20060173087A1 (en) * | 2003-03-12 | 2006-08-03 | Hyde Patrick D | Absorbent polymer compositions, medical articles, and methods |
US7285576B2 (en) | 2003-03-12 | 2007-10-23 | 3M Innovative Properties Co. | Absorbent polymer compositions, medical articles, and methods |
US20040180093A1 (en) * | 2003-03-12 | 2004-09-16 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20110118818A1 (en) * | 2003-06-17 | 2011-05-19 | Gel-Del Technologies ,Inc. a corporation | Encapsulated or coated stent systems |
US20060167540A1 (en) * | 2003-06-17 | 2006-07-27 | Masters David B | Encapsulated or coated stent systems |
US8465537B2 (en) | 2003-06-17 | 2013-06-18 | Gel-Del Technologies, Inc. | Encapsulated or coated stent systems |
US20050123590A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Wound dressings and methods |
US20050123621A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
US20050124724A1 (en) * | 2003-12-05 | 2005-06-09 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US8193267B2 (en) | 2003-12-05 | 2012-06-05 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20100233273A1 (en) * | 2003-12-05 | 2010-09-16 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US20050196440A1 (en) * | 2003-12-08 | 2005-09-08 | Masters David B. | Mucoadhesive drug delivery devices and methods of making and using thereof |
US8529939B2 (en) | 2003-12-08 | 2013-09-10 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
US8951565B2 (en) | 2003-12-23 | 2015-02-10 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
US8795710B2 (en) | 2004-02-09 | 2014-08-05 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
US20050283256A1 (en) * | 2004-02-09 | 2005-12-22 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
US20090030526A1 (en) * | 2004-02-09 | 2009-01-29 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
US8920443B2 (en) | 2004-02-17 | 2014-12-30 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
US11583276B2 (en) | 2004-02-17 | 2023-02-21 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
US10512463B2 (en) | 2004-02-17 | 2019-12-24 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
US20080200949A1 (en) * | 2004-02-17 | 2008-08-21 | Hiles Michael C | Medical devices and methods useful for applying bolster material |
US9186140B2 (en) | 2004-02-17 | 2015-11-17 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
US20060004407A1 (en) * | 2004-02-17 | 2006-01-05 | Hiles Michael C | Medical devices and methods useful for applying bolster material |
US8920444B2 (en) | 2004-02-17 | 2014-12-30 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
US20070027472A1 (en) * | 2004-02-17 | 2007-02-01 | Hiles Michael C | Medical devices and methods useful for applying bolster material |
US20060034899A1 (en) * | 2004-08-12 | 2006-02-16 | Ylitalo Caroline M | Biologically-active adhesive articles and methods of manufacture |
US20060035039A1 (en) * | 2004-08-12 | 2006-02-16 | 3M Innovative Properties Company | Silver-releasing articles and methods of manufacture |
US9204957B2 (en) | 2005-03-17 | 2015-12-08 | Hemcon Medical Technologies, Inc. | Systems and methods for hemorrhage control and or tissue repair |
US20060211973A1 (en) * | 2005-03-17 | 2006-09-21 | Gregory Kenton W | Systems and methods for hemorrhage control and or tissue repair |
US20060233889A1 (en) * | 2005-04-14 | 2006-10-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
US8399027B2 (en) | 2005-04-14 | 2013-03-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
US20070038298A1 (en) * | 2005-06-30 | 2007-02-15 | Sulner Joseph W | Repair of tympanic membrane using placenta derived collagen biofabric |
US8029774B2 (en) * | 2005-07-01 | 2011-10-04 | University Of Pittsburgh | Wound healing polymeric networks |
US20070014755A1 (en) * | 2005-07-01 | 2007-01-18 | Beckman Eric J | Wound healing polymeric networks |
US20070073415A1 (en) * | 2005-09-29 | 2007-03-29 | Codman And Shurtleff, Inc. | Dural graft and method of preparing the same |
US20080208359A1 (en) * | 2005-09-29 | 2008-08-28 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
US7429241B2 (en) | 2005-09-29 | 2008-09-30 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
US7517536B2 (en) | 2005-11-25 | 2009-04-14 | Feng Chia University | Antimicrobial compositions and wound dressings |
US20090211693A1 (en) * | 2005-12-16 | 2009-08-27 | Molynlycke Health Care Ab | Method for perforating heat meltable material |
US8177931B2 (en) | 2005-12-16 | 2012-05-15 | Molnlycke Health Care Ab | Method for perforating heat meltable material |
US20080279960A1 (en) * | 2006-01-13 | 2008-11-13 | Burton Scott A | Silver-Containing Antimicrobial Articles and Methods of Manufacture |
US20070166399A1 (en) * | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
US8192764B2 (en) | 2006-01-13 | 2012-06-05 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
US9289450B2 (en) | 2006-01-13 | 2016-03-22 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
US20080287907A1 (en) * | 2006-05-23 | 2008-11-20 | Providence Health System-Oregan D/B/A Providence St. Vincent Medical Center | Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ |
US8920514B2 (en) | 2006-05-23 | 2014-12-30 | Providence Health System—Oregon | Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ |
US20080069895A1 (en) * | 2006-08-15 | 2008-03-20 | Qing Liu | Umbilical cord biomaterial for medical use |
US8105634B2 (en) | 2006-08-15 | 2012-01-31 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
US9414601B2 (en) | 2006-09-07 | 2016-08-16 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20080121592A1 (en) * | 2006-09-07 | 2008-05-29 | Biolargo Life Technologies, Incorporated | Systems and methods for cleaning liquid carriers related applications data |
US8574610B2 (en) | 2006-09-07 | 2013-11-05 | Biolargo Life Technologies, Inc. | Material having antimicrobial activity when wet |
US20110104303A1 (en) * | 2006-09-07 | 2011-05-05 | Biolargo Life Technologies, Inc. | Material having antimicrobial activity when wet |
US20080063694A1 (en) * | 2006-09-07 | 2008-03-13 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20090028915A1 (en) * | 2006-09-07 | 2009-01-29 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US8226964B2 (en) | 2006-09-07 | 2012-07-24 | Biolargo Life Technologies, Inc. | Systems and methods for cleaning liquid carriers related applications data |
US7867510B2 (en) | 2006-09-07 | 2011-01-11 | BioLargo Life Technologies, Inc | Material having antimicrobial activity when wet |
US20080131522A1 (en) * | 2006-10-03 | 2008-06-05 | Qing Liu | Use of placental biomaterial for ocular surgery |
US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
US9974840B2 (en) | 2006-10-06 | 2018-05-22 | Celularity, Inc. | Human placental collagen compositions, and methods of making and using the same |
US8821857B2 (en) | 2006-10-06 | 2014-09-02 | Anthrogenesis Corporation | Human placental collagen compositions and methods of making and using the same |
US8877180B2 (en) | 2006-10-06 | 2014-11-04 | Anthrogenesis Corporation | Human placental collagen compositions, and methods of making and using the same |
US20080181935A1 (en) * | 2006-10-06 | 2008-07-31 | Mohit Bhatia | Human placental collagen compositions, and methods of making and using the same |
US9775886B2 (en) | 2006-10-06 | 2017-10-03 | Celularity, Inc. | Human placental collagen compositions, and methods of making and using the same |
EP2664342A2 (en) | 2006-10-06 | 2013-11-20 | Anthrogenesis Corporation | Native (telopeptide) placental collagen compositions |
US9770488B2 (en) | 2006-10-06 | 2017-09-26 | Anthrogenesis Corporation | Human placental collagen compositions, and methods of making and using the same |
EP2664341A2 (en) | 2006-10-06 | 2013-11-20 | Anthrogenesis Corporation | Native (telopeptide) placental collagen compositions |
US20100098949A1 (en) * | 2006-10-18 | 2010-04-22 | Burton Scott A | Antimicrobial articles and method of manufacture |
WO2008065329A3 (en) * | 2006-11-30 | 2009-01-08 | Ethicon Inc | Protein sheet material |
WO2008065329A2 (en) * | 2006-11-30 | 2008-06-05 | Systagenix Wound Management Ip Co. B.V. | Protein sheet material |
US20080146983A1 (en) * | 2006-12-19 | 2008-06-19 | Biopol Co., Ltd. | Polyurethane foam dressing with improved moisturization |
US7777091B2 (en) * | 2006-12-19 | 2010-08-17 | Biopol Co., Ltd. | Polyurethane foam dressing with improved moisturization |
US20090128716A1 (en) * | 2007-11-15 | 2009-05-21 | Funai Electric Co., Ltd. | Projector and method for projecting image |
US20100143487A1 (en) * | 2007-12-26 | 2010-06-10 | Gel-Del Technologies, Inc. | Biocompatible protein-based particles and methods thereof |
US11890371B2 (en) | 2007-12-26 | 2024-02-06 | Petvivo Holdings, Inc. | Biocompatible protein-based particles and methods thereof |
US20090269413A1 (en) * | 2008-04-23 | 2009-10-29 | Codman & Shurtleff, Inc. | Flowable collagen material for dural closure |
US8039591B2 (en) | 2008-04-23 | 2011-10-18 | Codman & Shurtleff, Inc. | Flowable collagen material for dural closure |
US9205170B2 (en) | 2008-05-02 | 2015-12-08 | Hemcon Medical Technologies, Inc. | Wound dressing devices and methods |
US20100172958A1 (en) * | 2008-05-02 | 2010-07-08 | Hemcon Medical Technologies, Inc. | Wound dressing devices and methods |
EP2315555A2 (en) * | 2008-08-07 | 2011-05-04 | Manuela Singer | Reusable medical protective clothing for pets and farm animals after surgeries and with skin diseases |
US10086105B2 (en) | 2008-10-06 | 2018-10-02 | Providence Health System—Oregon | Chitosan foam medical devices and methods |
DE202011100392U1 (en) | 2011-05-07 | 2011-06-09 | Neubauer, Norbert, 38820 | Burns Edition |
US9403953B2 (en) | 2011-07-06 | 2016-08-02 | Diversified Global Technologies, Llc | Cosmetic sponge and method for providing a cosmetic sponge |
US20150125512A1 (en) * | 2012-03-13 | 2015-05-07 | Aap Biomaterials Gmbh | Antibacterial sheet material that can be used as a wound dressing and method for producing same |
US9849611B2 (en) | 2012-03-13 | 2017-12-26 | Aap Biomaterials Gmbh | Method for producing collagen-containing sheet material |
US10478521B2 (en) * | 2012-03-13 | 2019-11-19 | Aap Implantate Ag | Antibacterial sheet material that can be used as a wound dressing and method for producing same |
WO2013135478A1 (en) * | 2012-03-13 | 2013-09-19 | Aap Biomaterials Gmbh | Antibacterial sheet material that can be used as a wound dressing and method for producing same |
EP3360585A1 (en) | 2013-03-15 | 2018-08-15 | Celularity, Inc. | Improved method of making extracellular matrix compositions |
US9089366B2 (en) | 2013-04-04 | 2015-07-28 | Steven Garner-Richards | System for tracking surgical objects |
US10058455B2 (en) | 2013-06-10 | 2018-08-28 | Ultramend, Inc. | Nano-enhanced wound dressing |
US11844671B2 (en) | 2013-06-10 | 2023-12-19 | Ultramend, Inc. | Nano-enhanced wound dressing |
US20160129151A1 (en) * | 2014-11-06 | 2016-05-12 | Case Western Reserve University | Protein based materials |
WO2019056819A1 (en) * | 2017-09-22 | 2019-03-28 | 青岛明月生物医用材料有限公司 | Collagen-loaded alginate medical dressing and preparation method therefor |
EP4285944A1 (en) * | 2022-06-01 | 2023-12-06 | MedSkin Solutions Dr. Suwelack AG | Method of making a composition with a film-coated porous material |
WO2023232944A2 (en) | 2022-06-01 | 2023-12-07 | Medskin Solutions Dr. Suwelack Ag | Method of making a composition with a film-coated porous material |
WO2023232944A3 (en) * | 2022-06-01 | 2024-01-11 | Medskin Solutions Dr. Suwelack Ag | Method of making a composition with a film-coated porous material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3800792A (en) | Laminated collagen film dressing | |
Pruitt et al. | Characteristics and uses of biologic dressings and skin substitutes | |
US5350583A (en) | Cell-penetrable medical material and artificial skin | |
Chvapil | Considerations on manufacturing principles of a synthetic burn dressing: a review | |
US5676967A (en) | Mesh matrix wound dressing | |
Yannas et al. | Design of an artificial skin. I. Basic design principles | |
Davies | Synthetic materials for covering burn wounds: progress towards perfection. Part I. Short term dressing materials | |
Suzuki et al. | Clinical evaluation of a new bilayer “artificial skin” composed of collagen sponge and silicone layer | |
US5607590A (en) | Material for medical use and process for preparing same | |
CA1202904A (en) | Chitosan based wound dressing materials | |
CA2400398C (en) | Multilayer collagen matrix for tissue reconstruction | |
CA1213521A (en) | Hydrophilic biopolymeric copolyelectrolytes, and biodegradable dressings comprising same | |
EP0637452B1 (en) | Collagen membrane material for medical use and process for preparing the same | |
US5263983A (en) | Medical material and prosthetic skin in which cells can invade | |
EP0265906B1 (en) | Wound dressing | |
Queen et al. | Burn wound dressings—a review | |
ALEXANDER et al. | Clinical evaluation of Epigard, a new synthetic substitute for homograft and heterograft skin | |
JPS587251A (en) | Bandage for composite wound | |
JPH08294530A (en) | Cardiovascular restoration material and its production | |
FI71944C (en) | Hydrophilic biopolymer copolyelectrolytes, and these contain biodegradable wound dressings. | |
EP0411124B1 (en) | Medical material permitting cells to enter thereinto and artificial skin | |
JPH04303445A (en) | Wound covering material | |
JPS62246370A (en) | Wound covering material | |
US20020168400A1 (en) | Collagen/synthetic resin foam wound dressing | |
JP2645098B2 (en) | Antibacterial agent-containing artificial skin and method for producing the same |